Financhill
Back

Context Therapeutics Stock Predictions

Context Therapeutics Stock Forecast

  • Is Context Therapeutics Stock Undervalued?
    The current Context Therapeutics [CNTX] share price is $1.39. The Score for CNTX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • CNTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Context Therapeutics Stock Go Up Next Year?

Data Unavailable

Context Therapeutics Stock Rating

Data Unavailable

Context Therapeutics Stock Price History

Is CNTX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
contexttherapeutics.com

52-Week Data

52-Week High:
2.75
52-Week Low:
0.77

Prediction Charts

Market Cap:
104.25M
Price in USD:
1.39
Volume:
784.97K
Beta:
2.22

Technical Analysis

SMA50:
2.00
SMA100:
2.14
SMA200:
1.83
52-Wk Change:
63.41%

Stock Predictions

  • Is Context Therapeutics stock public?
    Yes, Context Therapeutics is a publicly traded company.
  • What is the Context Therapeutics stock quote today?
    The Context Therapeutics stock price is 1.39 USD today.
  • How to buy Context Therapeutics stock online?
    You can buy Context Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 2.23 2.21 2.26 2.14
Nov-6 2.32 2.22 2.32 2.17
Nov-7 2.25 2.09 2.25 2.07
Nov-8 2.06 1.95 2.09 1.90
Nov-11 1.95 2.05 2.07 1.93
Nov-12 2.03 2.06 2.10 1.94
Nov-13 2.07 1.97 2.10 1.96
Nov-14 1.97 1.90 1.97 1.84
Nov-15 1.84 1.84 1.89 1.78
Nov-18 1.84 1.68 1.84 1.56
Nov-19 1.61 1.65 1.74 1.61
Nov-20 1.65 1.63 1.67 1.51
Nov-21 1.53 1.50 1.58 1.32
Nov-22 1.35 1.39 1.43 1.27

Context Therapeutics Earnings

Data Unavailable

Context Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.91 per share, and an increase next year of $0.21 per share.

* Context Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.